Navidea Biopharmaceuticals (NAVB +3.2%) moves up today after pricing its 1.54M shares secondary offering at $3.10 per share, just a penny shy of yesterday's close. The gross proceeds of sale total approximately $4.8M, and the company plans to use the proceeds to fund it's ongoing operations.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.